Turning distress into distraction: using virtual reality during penicillin injections for rheumatic fever.

N Z Med JSep 25, 2026 (epub)
Clinical ResearchPediatricsRheumatology

Julie Cooper, Jacqui Ulugia, Dhevindri Moodley et al.

✦ AI-curated · Sources linked

In 30 seconds

This phase IIA clinical trial evaluated the use of immersive virtual reality (VR) during subcutaneous penicillin injections in 10 participants aged 9-20 years with acute rheumatic fever. The study found that VR significantly reduced mean pain scores from 5.1 to 3.3 and anxiety scores from 3.4 to 1.1, indicating improved injection acceptability.

Key findings

  • Mean pain scores decreased from 5.1 (usual) to 3.3 (current) during injections.
  • Mean anxiety scores dropped from 3.4 (pre-injection) to 1.1 (post-injection).
  • All participants expressed a willingness to use VR again and recommend it to others.
  • Nurses observed faster procedures and calmer patients when VR was used.

Why it matters

The use of VR as a distraction during painful procedures may enhance patient comfort and compliance, particularly in pediatric populations requiring frequent injections. This approach could lead to improved overall treatment experiences.

Source

Published in N Z Med J. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.